Thermo Fisher launches HIV-1 genotyping kit

Create PDF

September 2022—Thermo Fisher Scientific launched its Applied Biosystems HIV-1 Genotyping Kit with Integrase, a research use only assay that examines positive samples of human immunodeficiency virus to identify genetic variants that resist common antiretroviral therapeutics.

The kit will analyze expanded targets associated with HIV drug resistance that include mutations in the integrase region of the pol gene on Applied Biosystems Sanger sequencing CE instrumentation and has been designed to offer broad group M subtype coverage. It is compatible with the recently launched Applied Biosystems MagMax Viral/Pathogen Nucleic Acid Isolation Kit for HIV-1 blood spots.